Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 1
1999 4
2000 3
2002 1
2003 3
2005 2
2006 1
2007 1
2008 1
2012 1
2013 3
2015 1
2016 1
2017 1
2018 4
2019 2
2020 9
2021 19
2022 14
2023 19
2024 8
2025 37
2026 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.
Şahin G, Tüzün EK, Güzel HG, Guliyev M, Dişli AK, Yazıcı M, Yıldız O, Güneş TK, Alkan S, Kahraman EG, Özel GS, İçli MC, Şahin E, Muğlu H, Acar C, Tunbekici S, Yüksel HÇ, Yücel H, Kahya BU, Kitaplı S, Büyükşimşek M, İpek ŞA, Dama PE, Usta EA, Yılmaz M, Aşık E, Özalp FR, Savsar MG, Kocaaslan E, Sim S, Ağaoğlu AB, Çamöz ES, Demir T, Uyar GC, Yıldırım A, Çınkır HY, Salim DK, Doğu GG, Alan Ö, Bayram E, Karaçin C, Güç ZG, Ekinci F, Eryılmaz MK, Semiz HS, Ünal OÜ, Göksu SS, Öztürk B, İnanç M, Uygun K, Hacıbekiroğlu İ, Erçolak V, Kara İO, Yazıcı O, Bilici A, Tanrıverdi Ö, Karaca B, Erman M, Gökmen E, Göker E, Yıldırım HÇ. Şahin G, et al. Among authors: ekinci f. Int J Cancer. 2026 Feb 15;158(4):1067-1079. doi: 10.1002/ijc.70165. Epub 2025 Sep 19. Int J Cancer. 2026. PMID: 40968962
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group.
Tunbekici S, Sahin G, Ön S, Oruc A, Eryılmaz MK, Sakin A, Coskun A, Seyyar M, Uzundere FK, Kolemen E, Cabuk D, Efil SC, Demir T, Turkmen E, Ekinci F, Terzi A, Sahin TK, Guven DC, Aksoy S, Aytac A, Demirkıran Ö, Demir B, Culcuoglu I, Ersoy M, Asarkaya E, Camanlı U, Gezici B, Ozveren A, Sevınc A, Kitaplı S, Unlu A, Ozturk B, Turkel A, Dogan M, Aslan F, Yesilbas E, Kaplan E, Sakalar T, Sahin E, Emin G, Asık E, Yıldırım A, Guclu T, Ugurlu I, Kahvecioglu F, Hacıbekiroglu I, Tunbekici I, Bayram S, Kaya AO, Majidova N, Yalıcı O, Karateke M, Avcı N, Belen B, Bal H, Kınıkoglu O, Turkoz FP, Sımsek ET, Altınok O, Gunes TK, Altıntas YE, Guliyev M, Ozturk G, Erdem D, Duzkopru Y, Inal A, Guren AK, Yıldırım N, Telli TA, Danacı Y, Aydın U, Almuradova E, Yıldırım HC, Gursoy P, Sendur MAN, Goker E. Tunbekici S, et al. Among authors: ekinci f. Int J Cancer. 2026 Apr 1;158(7):1881-1890. doi: 10.1002/ijc.70213. Epub 2025 Oct 28. Int J Cancer. 2026. PMID: 41147655
An Assessment of Intermittent and Continuous Enteral Feeding in Critically Ill Children.
Misirlioglu M, Yildizdas D, Ekinci F, Akcay N, Bingol I, Sahin E, Varol F, Duyu M, Asik A, Durak F, Atman L, Bayraktar S, Alakaya M, Arslankoylu AE, Bozan G, Kiral E, Ozgur Horoz O, Telefon HA, Akkus A, Yazar A, Sandal O, Agin H, Koker A, Ulgen Tekerek N, Kutlu NO, Kilinc MA, Korulmaz A, Feray Ari H, Uysal Yazici M, Sevketoglu E, Menentoglu ME, Kacmaz E, Talay MN, Orhan O, Egehan Oruncu B, Kesici S, Odek C, Arslan D, Hepduman P, Evren G, Kinik Kaya HE, Yener N, Gun E, Gardiyanoglu I, Udurgucu M, Yavuz S, Avci A, Ozkale M, Ozkale Y, Yavas Kocaoglu DP, Sincar S, Coban Y. Misirlioglu M, et al. Among authors: ekinci f. Nutrients. 2025 Jan 15;17(2):301. doi: 10.3390/nu17020301. Nutrients. 2025. PMID: 39861429 Free PMC article.
Kidney Replacement Therapies and Outcomes in Children With Crush Syndrome-Associated Kidney Injury.
Demirkol D, Besci T, Havan M, Karacanoglu D, Kihtir HS, Yildizdas D, Duyu M, Özel A, Kocaoglu DPY, Gökay N, Durak F, Misirlioglu M, Kilinç MA, Sincar S, Varol F, Köker A, Dalkiran T, Yaman A, Akçay N, Göncü S, Talip M, Akkuzu E, Uçmak H, Kendirli T, Barlas Koçoglu Ü, Tufan E, Çebisli E, Ekinci F, Kutlu NO, Kocaoglu Ç, Koç G, Alakayav M, Çolak M, Önder C, Güvenç KB, Ülgen Tekerek N, Dursun O, Aygüler E, Gençay AG, Bayrakçi B. Demirkol D, et al. Among authors: ekinci f. JAMA Netw Open. 2025 Jan 2;8(1):e2456793. doi: 10.1001/jamanetworkopen.2024.56793. JAMA Netw Open. 2025. PMID: 39869334 Free PMC article.
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.
Sendur MAN, Hizal M, Çakar B, Aktepe OH, Eraslan E, Arık Z, Erturk İ, Aksoy S, Paydaş S, Değirmencioğlu S, Erol C, Demir N, Bulut G, Ak N, Özkan M, Sevinç A, Özdemir N, Dişel U, Tural D, Artaç M, Türk HM, Menekşe S, Göksu SS, Köse F, Geredeli C, Günaldı M, Uluç BO, Şen F, Oruç K, Ölmez ÖF, Sakin A, Demirci U, Erdem D, Ekinci F, Ökten N, Özer L, Okutur K, Demir A, Karadurmuş N, Akıncı MB, Yalçın B, Gökmen E. Sendur MAN, et al. Among authors: ekinci f. BMC Cancer. 2025 Nov 22;25(1):1897. doi: 10.1186/s12885-025-15287-2. BMC Cancer. 2025. PMID: 41275151 Free PMC article.
155 results